摘要
本文综述了原花青素、黄酮类的主要物质,对2型糖尿病(T2DM)和胰岛素抵抗的作用。我们阐明了原花青素对几种动物模型的作用,评估了它们对靶向组织的作用,分析了有关机制。研究发现原花青素在果糖或高脂诱导的胰岛素抵抗模型中的治疗可改善饮食诱导的损害,从而提高血糖和胰岛素敏感性。在胰腺 β无法抵消高血糖的后期阶段T2DM模型中也报道了同样的积极作用。在遗传性肥胖和食源性胰岛素抵抗模型中发现了更多有争议的结果。人类研究尽管有限,但进一步支持原花青素的降糖作用。关于机制,原花青素被发现能够靶向一些参与葡萄糖体内平衡的组织,这点在目前的综述中也被讨论。在胰岛素敏感组织中,原花青素调节葡萄糖摄取和脂肪生成、改善氧化/炎症阶段,其受损在T2DM发展中很重要。在产生胰岛素组织即胰腺中,原花青素调节胰岛素的分泌和产生和 β质量,尽管可得的结果不同。最后,内脏是原花青素的另一个潜在靶标。可得的数据表明活性、胰高血糖素样肽-1(GLP-1)水平的调节或许可解释这些已报道的天然产物降血糖作用。
关键词: β细胞,糖尿病,血糖,胰岛素抵抗,原花青素。
Current Medicinal Chemistry
Title:Procyanidins and Their Healthy Protective Effects Against Type 2 Diabetes
Volume: 22 Issue: 1
Author(s): Noemi Gonzalez-Abuin, Montserrat Pinent, Angela Casanova-Marti, Lluis Arola, Mayte Blay and Anna Ardevol
Affiliation:
关键词: β细胞,糖尿病,血糖,胰岛素抵抗,原花青素。
摘要: This review focuses on the role of procyanidins, the main group of flavonoids, on type 2 diabetes mellitus (T2DM) and insulin resistance. We compile the role of procyanidins on several animal models, and we evaluate their effects on target tissues and analyze the mechanisms involved. Procyanidin treatments in fructose or high-fat induced insulin resistant models were found to improve the damage induced by the diet, thus improving glycemia and insulin sensitivity. The same positive effects were also reported in models of late stage T2DM, in which pancreatic β-cells can no longer counteract hyperglycemia. More controversial results were found in genetically obese or cafeteria diet-induced insulin resistant models. Human studies, although limited, further support the hypoglycemic effect of procyanidins. Regarding their mechanisms, procyanidins have been found to target several tissues involved in glucose homeostasis, which is also discussed in the present review. In insulin-sensitive tissues, procyanidins modulate glucose uptake and lipogenesis and improve their oxidative/inflammatory state, the disruption of which is important in T2DM development. In the insulin-producing tissue, the pancreas, procyanidins modulate insulin secretion and production and β-cell mass, although the available results are divergent. Finally, the gut is another potential target for procyanidins. The available data suggest that modulation of the active glucagon-like peptide-1 (GLP-1) levels could partially explain the reported antihyperglycemic effect of these natural compounds.
Export Options
About this article
Cite this article as:
Noemi Gonzalez-Abuin, Montserrat Pinent, Angela Casanova-Marti, Lluis Arola, Mayte Blay and Ardevol Anna, Procyanidins and Their Healthy Protective Effects Against Type 2 Diabetes, Current Medicinal Chemistry 2015; 22 (1) . https://dx.doi.org/10.2174/0929867321666140916115519
DOI https://dx.doi.org/10.2174/0929867321666140916115519 |
Print ISSN 0929-8673 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-533X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Current Application of Cyclosporine A to Investigate Skeletal Muscle Adaptation
Current Enzyme Inhibition Aspirin and Clopidogrel: A Sweeping Combination in Cardiology
Current Medicinal Chemistry - Cardiovascular & Hematological Agents Management of Hypertension in Patients with Aortic Valvular Stenosis
Current Hypertension Reviews Platelets and Platelet Interaction with Progenitor Cells in Vascular Homeostasis and Inflammation
Current Vascular Pharmacology Acute Stroke Therapy: Combination Drugs and Multifunctional Neuroprotectants
Current Neuropharmacology Bone Marrow Cell Therapy in Clinical Trials: A Review of the Literature
Reviews on Recent Clinical Trials Thiazide Diuretics: 50 Years and Beyond
Current Hypertension Reviews Outcomes of Anticoagulant Therapy with Low-Molecular-Weight Heparin (LMWH) and Warfarin for Thromboangiitis Obliterans (TAO)
Current Vascular Pharmacology Does HbA1cc Play a Role in the Development of Cardiovascular Diseases?
Current Pharmaceutical Design Tocilizumab in SARS-CoV-2 Patients with the Syndrome of Cytokine Storm: A Narrative Review
Reviews on Recent Clinical Trials Hypertension and Heart Failure with Preserved Ejection Fraction: Connecting the Dots
Current Vascular Pharmacology Impact of Computational Structure-Based Predictive Toxicology in Drug Discovery
Combinatorial Chemistry & High Throughput Screening Targeting Mitochondrial Oxidative Stress Through Lipoic Acid Synthase: A Novel Strategy to Manage Diabetic Cardiovascular Disease
Cardiovascular & Hematological Agents in Medicinal Chemistry Novel Neuroendocrine and Metabolic Mechanism Provides the Patented Platform for Important Rejuvenation Therapies: Targeted Therapy of Telomere Attrition and Lifestyle Changes of Telomerase Activity with the Timing of Neuron-Specific Imidazole-Containing Dipeptide-Dominant Pharmaconutrition Provision
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery (Discontinued) Apolipoprotein A-I/HDL Infusion Therapy for Plaque Stabilization-Regression: A Novel Therapeutic Approach
Current Pharmaceutical Design Lipid Profile of Pig Tissues Contrasting in Meat Production
The Natural Products Journal Endothelial Dysfunction Induced by Cadmium and Mercury and its Relationship to Hypertension
Current Hypertension Reviews Appropriate Antibiotic Prescribing Pattern in Hospitalized Children
Current Drug Safety Targets and Patented Drugs for Chemotherapy of Chagas Disease in the Last 15 Years-Period
Recent Patents on Anti-Infective Drug Discovery Adherence to Secondary Prophylaxis Among Patients with Acute Rheumatic Fever and Rheumatic Heart Disease
Current Cardiology Reviews